Biopharmaceutical companies, being in a regulated industry, have always been focused on meeting quality requirements and controlling their supply chain. However, in the past few years they have had to deal with increasingly stringent regulatory demands to demonstrate that they are in control of not only their internal manufacturing processes, but the manufacturing processes of their raw material vendors…